Funding for this research was provided by:
Chang Gung Memorial Hospital (BMRPD69, CPRPG3H0011, CMRPD1H0392, BMRP611, CORPG3J0342)
Ministry of Science and Technology, Taiwan (106-2314-B-182-017-MY3, 107-2314-B-182A-051, 106-2314-B-182A-026-MY3)
Received: 3 August 2020
Accepted: 5 October 2020
First Online: 17 October 2020
Ethics approval and consent to participate
: Ethical approval was obtained from the institutional review board at Linkou Chang Gung Memorial Hospital, Taiwan (IRB No. 103-7584A and 201601675A0) with the clinical trials registered to Taiwan Food and Drug Administration (1040025953 and 1066015148) and Center of Drug Evaluation (104IND06124 and 106IND03071). The study protocol and procedure were complied with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare that they have no competing interests.